KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Capital Employed: 2016-2025

Historic Return on Capital Employed for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 0.04%.

  • BeOne Medicines' Return on Capital Employed rose 27.00% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 27.00%. This contributed to the annual value of -0.16% for FY2024, which is 16.00% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Return on Capital Employed is 0.04%, which was up 252.32% from -0.03% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Return on Capital Employed ranged from a high of 0.04% in Q3 2025 and a low of -0.38% during Q1 2023.
  • Over the past 3 years, BeOne Medicines' median Return on Capital Employed value was -0.24% (recorded in 2024), while the average stood at -0.21%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 22bps in 2022, then rose by 27bps in 2025.
  • Quarterly analysis of 5 years shows BeOne Medicines' Return on Capital Employed stood at -0.13% in 2021, then dropped by 22bps to -0.35% in 2022, then increased by 3bps to -0.31% in 2023, then grew by 16bps to -0.16% in 2024, then grew by 27bps to 0.04% in 2025.
  • Its Return on Capital Employed was 0.04% in Q3 2025, compared to -0.03% in Q2 2025 and -0.08% in Q1 2025.